Implementation of long-acting antiretroviral therapy in low-income and middle-income countries
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Implementation of long-acting antiretroviral therapy in low-income and middle-income countries
Authors
Keywords
-
Journal
Current Opinion in HIV and AIDS
Volume 17, Issue 3, Pages 127-134
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-04-19
DOI
10.1097/coh.0000000000000732
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of integrase inhibitors in HIV-associated tuberculosis in high-burden settings: implementation challenges and research gaps
- (2022) Anushka Naidoo et al. Lancet HIV
- Predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine
- (2021) Amy G. Cutrell et al. AIDS
- The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis
- (2021) Andrew N Phillips et al. Lancet Global Health
- Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial
- (2021) Jean-Michel Molina et al. Lancet HIV
- Long-acting antiretrovirals: a new era for the management and prevention of HIV infection
- (2021) Paul Thoueille et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
- (2021) Hans Jaeger et al. Lancet HIV
- Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study
- (2021) Chloe Orkin et al. Lancet HIV
- Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection
- (2020) Chloe Orkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
- (2020) Susan Swindells et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial
- (2020) Dirk Schürmann et al. Lancet HIV
- Pre-Treatment and Acquired Antiretroviral Drug Resistance among Persons Living with HIV in Four African Countries
- (2020) Trevor A Crowell et al. CLINICAL INFECTIOUS DISEASES
- Antibody-based strategies in HIV therapy
- (2020) Wesley D. Kufel INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study
- (2020) Ankur Gupta-Wright et al. Lancet HIV
- Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials
- (2019) Maria Buti et al. Lancet Gastroenterology & Hepatology
- HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa
- (2017) Cissy Kityo et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
- (2017) David A Margolis et al. LANCET
- Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa
- (2017) James Hakim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Steady-state pharmacokinetics of rilpivirine under different meal conditions in HIV-1-infected Ugandan adults
- (2015) Mohammed Lamorde et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa
- (2014) Nicholas I. Paton et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started